파나마 제약 등급 락토스 공급업체 및 가격 — 마켓 오버뷰 2026

상위 제품

유당

최종 업데이트

2026-07-16

서치 및 소싱 팀을 위한 핵심 요약

파나마의 제약 등급 락토스 마켓 인텔리전스 페이지에는 프리미엄 공급업체 0개가 포함되어 있습니다.
파나마에 대한 샘플 수출 거래 0건이 요약되어 있습니다.
파나마의 제약 등급 락토스에 대해 수출 파트너 기업 0개와 수입 파트너 기업 1개가 매핑되어 있습니다.
도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
수출 파트너 국가 0개와 수입 파트너 국가 0개가 랭킹되어 있습니다.
페이지 데이터 최종 업데이트일: 2026-07-16.

파나마의 제약 등급 락토스 수입 바이어 인텔리전스 및 가격 시그널: 바이어, 수요, 거래 파트너

파나마의 제약 등급 락토스에 대해 수입 파트너 기업 1개가 추적됩니다. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석을 활용해 바이어 수요, 파트너 밀도, 다운스트림 채널을 분석할 수 있습니다.

스캐터 포인트는 전체 거래 데이터셋의 100.0%에서 샘플링되었습니다.

제약 등급 락토스의 파나마 샘플 수입 거래 및 가격 기록

파나마의 제약 등급 락토스 샘플 수입 거래 1건은 가격 수준과 수요 측 거래 패턴 벤치마킹을 위한 날짜, 원산지, 무역 국가 맥락을 제공합니다.

파나마의 제약 등급 락토스 샘플 수입 거래 단가(일자별): 2025-11-08: 8.12 USD / kg.

일자	신고 품목	단가	수출업체	수입업체	원산지
2025-11-08	LAC**** * **** * ******* ***** * **** ***** *** *****	8.12 USD / kg	(-)	(-)	-

파나마 내 상위 제약 등급 락토스 바이어, 수입업체 및 수요 파트너

선도 바이어 프로필을 검토하고 파나마의 제약 등급 락토스에 대해 추적되는 전체 수입 파트너 기업 1개와 비교하세요. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석으로 수요 측 파트너 적합도를 평가할 수 있습니다.

(파나마)

최근 수입 거래: 2026-06-16

산업군: 기타

밸류체인 역할: 무역

파나마 수입 파트너 커버리지

1개 기업

수입 파트너 기업 수는 파나마의 제약 등급 락토스 수요 측 가시성을 보여줍니다.

공급망 인텔리전스 분석과 기업 프로필을 활용해 파나마에서 활동 중인 제약 등급 락토스 수입업체, 유통업체, 바이어 네트워크를 식별하세요.

Classification

Product TypeIngredient

Product FormPowder

Industry PositionPharmaceutical excipient (dairy-derived lactose)

Market

Pharmaceutical-grade lactose in Panama is primarily an import-dependent excipient market supporting local generic drug manufacturing, value-added distribution, and downstream pharmaceutical supply. For pharmaceutical manufacturing inputs, Panama Digital indicates that imported raw materials and the supplying company require registration with the National Directorate of Pharmacies and Drugs (DNFD), and importers must present an authenticated or original lot-by-lot quality control certificate from the country of origin. Panama’s customs tariff schedule lists lactose under HS 1702.11.00 and 1702.19.00 with a 0% import duty (DAI). Pharmaceutical manufacturing in Panama is described by PROPANAMA as not a significant economic sector, with production centered on a multinational plant and several local generic laboratories, implying modest but ongoing excipient demand for tablets/capsules and other basic dosage forms.

Market RoleNet importer; import-dependent pharmaceutical excipient market

Domestic RoleInput for local generic medicine manufacturing and value-added distribution/packaging operations; compliance-driven import channel via DNFD

Market GrowthNot Mentioned

Specification

Primary VarietyLactose monohydrate (pharmaceutical grade)

Secondary Variety

Anhydrous lactose (pharmaceutical grade)

Physical Attributes

Free-flowing white/off-white crystalline powder suitable for blending and compression (grade-dependent)
Hygroscopicity/moisture pick-up control is a key handling concern in Panama’s humid climate; packaging integrity and dry warehousing are important

Compositional Metrics

Pharmacopeial conformity testing typically covers appearance, acidity/alkalinity, specific optical rotation, absorbance, heavy metals, water/moisture, sulphated ash, and microbial contamination (per European Pharmacopoeia context referenced by EMA)
Batch-to-batch documentation (lot-by-lot) is central for qualification and DNFD-facing import dossiers

Grades

Pharmacopeial grade lactose (USP–NF and/or Ph. Eur.) for use as an excipient in finished medicines
Grade selection is driven by intended dosage form (e.g., standard blends vs. direct-compression performance needs) and the registered product dossier

Packaging

Sealed, moisture-barrier packaging (e.g., lined bags or drums) to protect against humidity during warehousing and distribution in Panama
Tamper-evident closures and clear lot/expiry labeling to support traceability and DNFD documentation workflows

Supply Chain

Value Chain

Qualified excipient manufacturer (typically overseas) → exporter → ocean freight to Panama → customs clearance → importer/distributor warehousing → distribution to local manufacturers and value-added distribution/packaging operators

Temperature

Ambient transport and storage is typical; avoid heat/humidity excursions that increase caking risk and compromise flow properties

Atmosphere Control

Moisture control (dry storage, desiccant/liners where applicable) is critical for powder integrity

Shelf Life

Shelf life is generally long when sealed and stored dry; shelf-life usability in Panama is highly sensitive to humidity exposure after opening and to warehouse moisture management

Freight IntensityMedium

Transport ModeSea

Risks

Regulatory Compliance HighMarket access can be blocked or materially delayed if pharmaceutical-grade lactose is imported as a raw material for local pharmaceutical manufacturing without the required DNFD inscription/registration and the authenticated/original lot-by-lot quality control certificate from the country of origin, as described in the Panamá Digital (MINSA) procedure.Confirm DNFD inscription status for the importer and supplying company before shipment; prepare authenticated/original lot-by-lot QC/CoA documentation in the exact format expected and reconcile it against shipping documents and labels.

Quality Assurance MediumSubstandard or non-pharmacopeial lactose (e.g., failing microbial/impurity limits or inconsistent physical performance) can trigger batch failure, product quality incidents, or regulatory nonconformities in locally produced or repackaged medicines.Source from qualified excipient manufacturers with robust GMP systems; require pharmacopeial compliance statements (USP–NF and/or Ph. Eur. as applicable), complete lot CoAs, and conduct incoming QC verification aligned to the finished product dossier.

Logistics MediumPanama’s role in global maritime logistics means that shipping disruptions and capacity constraints (including drought-driven operational restrictions affecting the Panama Canal) can contribute to broader schedule volatility and freight-rate swings that pressure lead times and inventories for imported excipients.Hold safety stock for critical excipients, diversify approved origins/routes where feasible, and monitor Panama Canal Authority advisories for early signals of capacity tightening that could cascade into regional freight congestion.

Sustainability

Animal-origin (milk-derived) supply chain: buyers and regulators may request origin/animal-material statements and risk assessments related to bovine-source materials (e.g., TSE/BSE considerations) depending on the finished medicine dossier and supplier practices.

Standards

WHO GMP expectations for excipients used in pharmaceutical products (quality management and control emphasis)
EXCiPACT GMP/GDP certification (commonly used third-party scheme for pharmaceutical excipient suppliers)
USP–NF excipient GMP guidance alignment (where used as a procurement/quality benchmark)

FAQ

What import duty applies to lactose in Panama under the national tariff schedule?Panama’s national tariff schedule lists lactose under HS 1702.11.00 and 1702.19.00 with a 0% import duty (DAI). Other taxes or fees may still apply depending on the transaction and classification.

What is a key document requirement when importing pharmaceutical manufacturing raw materials into Panama?For raw materials imported to be used in manufacturing pharmaceutical products in Panama, Panamá Digital (MINSA) indicates the importer must present an authenticated copy or the original of the quality control certificate from the country of origin, lot by lot.

Which authority is referenced for registering/importing pharmaceutical manufacturing raw materials in Panama?Panamá Digital (MINSA) states that the imported raw material used for pharmaceutical manufacturing and the supplying company require inscription with the National Directorate of Pharmacies and Drugs (DNFD) of the Ministry of Health.